Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting.

Volume: 56, Issue: 8, Pages: 906 - 913
Published: Aug 3, 2021
Abstract
Objectives null We set out to determine the reasons for serum vedolizumab (VDZ) trough concentration (TC) measurements in inflammatory bowel disease (IBD) patients and to evaluate treatment modifications after therapeutic drug measurement (TDM). We also evaluated the effect of increased dosing on patients' response to VDZ therapy. null Methods null We performed a retrospective cohort study of IBD patients who received VDZ therapy at Helsinki...
Paper Details
Title
Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting.
Published Date
Aug 3, 2021
Volume
56
Issue
8
Pages
906 - 913
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.